Actively Recruiting
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
Led by Istituto Nazionale di Ricovero e Cura per Anziani · Updated on 2026-02-27
400
Participants Needed
3
Research Sites
63 weeks
Total Duration
On this page
Sponsors
I
Istituto Nazionale di Ricovero e Cura per Anziani
Lead Sponsor
M
Ministry of Health, Italy
Collaborating Sponsor
AI-Summary
What this Trial Is About
The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.
CONDITIONS
Official Title
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized for acute neurological disorders including ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis, or meningitis
- Inpatients diagnosed with major neurocognitive disorder (dementia) according to DSM-5 criteria
- Inpatients with non-neurological diseases without dementia
- Age 65 years or older
- Ability to provide informed consent or have a legal representative provide consent
You will not qualify if you...
- Lack of informed consent
- Patients with ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis, or meningitis excluded from non-neurological groups
- Diagnosis of dementia excluded from non-neurological without dementia group
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
IRCCS INRCA Hospital
Ancona, Italy
Actively Recruiting
2
IRCCS INRCA Hospital
Fermo, Italy
Actively Recruiting
3
Policlinico Universitario
Messina, Italy
Actively Recruiting
Research Team
A
Anna Rita Bonfigli
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here